HOME >> BIOLOGY >> NEWS
Researchers identify protein promoting vascular tumor growth

COLUMBUS, Ohio Researchers have discovered a new mechanism responsible for the growth of blood vessel tumors that can cause facial deformities in infants and young children, paving the way for an antibody-based treatment to remove cells that fuel the tumors' growth.

Blood vessel tumors require macrophages, a type of white blood cells, to develop. In studying these cells' role in tumor development, Ohio State University medical researchers determined that a protein called MCP-1 "recruits" macrophages to the vascular tumor site.

This means that therapies to eliminate the MCP-1 protein could be a key to healing or preventing the tumors and possibly others in which MCP-1 is expressed.

The results are published in the October issue of the American Journal of Physiology (Cell).

Blood vessel tumors affect up to 3 percent of all children, typically resulting in a prominent red mass on the head and neck. Up to one in four patients with hemangioendotheliomas, or HEs, the type of tumor used in these studies, die of anemia associated with the tumors.

The findings present the first evidence that MCP-1 and macrophages are needed for these tumors to grow, and the first evidence that anti-MCP-1 therapy prevents vascular tumor development in animals with intact immune systems, said Gayle Gordillo, lead author of the study, assistant professor of plastic surgery and an investigator in the Davis Heart and Lung Research Institute at Ohio State University Medical Center.

When MCP-1 recruits macrophages to the tumor site, it stimulates new blood vessel development, or angiogenesis, in endothelial cells that make up the lining of blood vessels. That proliferation can cause the tumors to grow because new vessels develop and allow blood to collect in the lesion. Gordillo, in partnership with Heart and Lung Research Institute investigators Chandan Sen and Sashwati Roy, determined MCP-1's role in recruiting macrophages by
'"/>

Contact: Emily Caldwell
caldwell.151@osu.edu
614-293-3737
Ohio State University
29-Sep-2004


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers devise potent new tools to curb ivory poaching
4. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
5. Researchers ID chlorophyll-regulating gene
6. Researchers develop fast track way to discover how cells are regulated
7. Researchers identify distinctive signature for metastatic prostate cancer
8. Researchers report new gene test for isolated cleft lip and palate
9. Researchers discover why mutant gene causes colon cancer
10. Researchers identify the genomes controlling elements
11. Researchers improve detection of diverse anthrax strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2019)... , ... December 17, 2019 , ... ... pharmaceutical, biotech, medical device, and diagnostics industries, has named Pharmafusion LLC as one ... impressive year for the company and its founder/CEO Jonathan Retano. Earlier in the ...
(Date:12/14/2019)... ... December 10, 2019 , ... A study by researchers in ... are able to reduce the virulence of, and even prevent infections by, several ... individuals, including the multi-drug resistant Candida auris, which was recently listed as an ...
(Date:12/14/2019)... JOSE, Calif. (PRWEB) , ... December 12, 2019 ... ... sustainable agrochemical products that protect or enhance crop yields, has appointed Jean Pougnier ... strategic partners and establish relationships with go-to-market partners and influencers that will position ...
Breaking Biology News(10 mins):
(Date:12/27/2019)... ... December 27, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries is excited to celebrate the completion ... CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization plan was implemented ...
(Date:12/18/2019)... ... 17, 2019 , ... Innovative Health, Inc. today ... devices since the company’s inception in 2016. This marks a record in the ... Johnson company) have received 2 and 4 EP device clearances, respectively, in the ...
(Date:12/14/2019)... (PRWEB) , ... December 12, 2019 , ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... of 2019. The new LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium ... UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at ...
Breaking Biology Technology:
Cached News: